200,000+ products from a single source!

sales@angenechem.com

Home > Pyridines > 103-74-2

103-74-2

103-74-2 | 2-Pyridineethanol

CAS No: 103-74-2 Catalog No: AG00381A MDL No:MFCD00006364

Product Description

Catalog Number:
AG00381A
Chemical Name:
2-Pyridineethanol
CAS Number:
103-74-2
Molecular Formula:
C7H9NO
Molecular Weight:
123.1525
MDL Number:
MFCD00006364
IUPAC Name:
2-pyridin-2-ylethanol
InChI:
InChI=1S/C7H9NO/c9-6-4-7-3-1-2-5-8-7/h1-3,5,9H,4,6H2
InChI Key:
BXGYBSJAZFGIPX-UHFFFAOYSA-N
SMILES:
OCCc1ccccn1
EC Number:
203-140-2
UNII:
4G94J9B8JR

Properties

Complexity:
75.3  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
123.068g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
123.155g/mol
Monoisotopic Mass:
123.068g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
33.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.1  

Literature

Title Journal
Nitric oxide reactivity of copper(II) complexes of bidentate amine ligands: effect of chelate ring size on the stability of a [Cu(II)-NO] intermediate. Dalton transactions (Cambridge, England : 2003) 20120821
Bis(acetato-κO)bis-[2-(pyridin-2-yl)ethanol-κ(2)N,O]copper(II). Acta crystallographica. Section E, Structure reports online 20120501
Bis[μ-2-(pyridin-2-yl)ethano-lato]bis-[bromidocopper(II)]. Acta crystallographica. Section E, Structure reports online 20111101
Bis[2-(pyridin-2-yl)ethanol-κN,O]bis-(thio-cyanato-κN)nickel(II). Acta crystallographica. Section E, Structure reports online 20101201
Nuclearity of nickel and mixed sodium-nickel complexes: dependence on the spacer in chelating pyridine-alcoholate ligands. Chemical communications (Cambridge, England) 20100921
Family of Mn(III)(2)Ln(2)(mu(4)-O) compounds: syntheses, structures, and magnetic properties. Inorganic chemistry 20100607
Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis. Journal of analytical toxicology 20100301
Bis(dicyanamido-κN)bis-[2-(2-hydroxy-ethyl)pyridine-κN,O]nickel(II). Acta crystallographica. Section E, Structure reports online 20091201
Vapor-diffusion-mediated single crystal-to-single crystal transformation of a discrete dimeric copper(II) complex to a discrete tetrameric copper(II) complex. Inorganic chemistry 20090601
2,2'-Diamino-N,N'-(o-phenyl-ene)di-benz-amide. Acta crystallographica. Section E, Structure reports online 20090401
Oxethazaine as the source of mephentermine and phentermine in athlete's urine. Forensic science international 20090310
Bis[2-(2-hydroxyethyl)pyridinium] mu-decavanadato-bis[pentaaquamanganate(II)] tetrahydrate. Acta crystallographica. Section C, Crystal structure communications 20090201
Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070401
Palladium-catalyzed 2-pyridylmethyl transfer from 2-(2-pyridyl)ethanol derivatives to organic halides by chelation-assisted cleavage of unstrained C(sp3 )--C(sp3) bonds. Angewandte Chemie (International ed. in English) 20070101
Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PloS one 20070101
Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety. Bioorganic & medicinal chemistry 20060815
Intrahepatic flow disturbance: possibility of a hidden cause of drug toxicity. Journal of pharmacological sciences 20060301
Mechanisms involved in the contraction of intrahepatic portal vein branches by clomipramine and oxethazaine in isolated perfused rat livers. Journal of pharmacological sciences 20050601
Single-molecule magnets: structure and properties of [Mn18O14(O2CMe)18(hep)4(hepH)2(H2O)2](ClO4)2 with spin S = 13. Inorganic chemistry 20050207
[Clinical study on the pharmacological treatment of hemorrhoids with 0.25% oxethacaine chlorhydrate]. La Clinica terapeutica 20041001
Large spin differences in structurally related Fe6 molecular clusters and their magnetostructural explanation. Inorganic chemistry 20040906
Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol. Bioorganic & medicinal chemistry 20030915
Quantum tunneling of magnetization in a new [Mn18]2+ single-molecule magnet with s = 13. Journal of the American Chemical Society 20020821
Biphasic effects of oxethazaine, a topical anesthetic, on the intracellular Ca(2+) concentration of PC12 cells. Biochemical pharmacology 20020815
Metabolism of a thiazole benzenesulfonamide derivative, a potent and elective agonist of the human beta3-adrenergic receptor, in rats: identification of a novel isethionic acid conjugate. Drug metabolism and disposition: the biological fate of chemicals 20020701
Single-molecule magnets: a new family of Mn(12) clusters of formula [Mn(12)O(8)X(4)(O(2)CPh)(8)L(6)]. Journal of the American Chemical Society 20020410
Effects of betahistine and of its metabolites on vestibular sensory organs. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20010601
Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. Pharmacological research 20010401
[[Separation of oxetacaine and its metabolites] ]. Die Pharmazie 20010101

© 2019 Angene International Limited. All rights Reserved.